AAAAAA

   
Results: 1-11 |
Results: 11
Interleukin-10
Authors: Narula, S Cuss, F
Citation: S. Narula et F. Cuss, Interleukin-10, PROG R RES, 31, 2001, pp. 269-273
Type 1 T regulatory cells
Authors: Roncarolo, MG Bacchetta, R Bordignon, C Narula, S Levings, MK
Citation: Mg. Roncarolo et al., Type 1 T regulatory cells, IMMUNOL REV, 182, 2001, pp. 68-79
Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death
Authors: Wiekowski, MT Leach, MW Evans, EW Sullivan, L Chen, SC Vassileva, G Bazan, JF Gorman, DM Kastelein, RA Narula, S Lira, SA
Citation: Mt. Wiekowski et al., Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death, J IMMUNOL, 166(12), 2001, pp. 7563-7570
Altered T-cell receptor+CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease
Authors: Boussiotis, VA Chen, ZM Zeller, JC Murphy, WJ Berezovskaya, A Narula, S Roncarolo, MG Blazar, BR
Citation: Va. Boussiotis et al., Altered T-cell receptor+CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease, BLOOD, 97(2), 2001, pp. 565-571
Structure-based design of an osteoclast-selective, nonpeptide Src homology2 inhibitor with in vivo antiresorptive activity
Authors: Shakespeare, W Yang, M Bohacek, R Cerasoli, F Stebbins, K Sundaramoorthi, R Azimioara, M Vu, C Pradeepan, S Metcalf, C Haraldson, C Merry, T Dalgarno, D Narula, S Hatada, M Lu, XD van Schravendijk, MR Adams, S Violette, S Smith, J Guan, W Bartlett, C Herson, J Iuliucci, J Weigele, M Sawyer, T
Citation: W. Shakespeare et al., Structure-based design of an osteoclast-selective, nonpeptide Src homology2 inhibitor with in vivo antiresorptive activity, P NAS US, 97(17), 2000, pp. 9373-9378
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: Antagonism by anandamide
Authors: Gonsiorek, W Lunn, C Fan, XD Narula, S Lundell, D Hipkin, RW
Citation: W. Gonsiorek et al., Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: Antagonism by anandamide, MOLEC PHARM, 57(5), 2000, pp. 1045-1050
Investigating protein-ligand interactions with a mutant FKBP possessing a designed specificity pocket
Authors: Yang, W Rozamus, LW Narula, S Rollins, CT Yuan, R Andrade, LJ Ram, MK Phillips, TB van Schravendijk, MR Dalgarno, D Clackson, T Holt, DA
Citation: W. Yang et al., Investigating protein-ligand interactions with a mutant FKBP possessing a designed specificity pocket, J MED CHEM, 43(6), 2000, pp. 1135-1142
Selective epimerization of rapamycin via a retroaldol/aldol mechanism mediated by titanium tetraisopropoxide
Authors: Yang, W Digits, CA Hatada, M Narula, S Rozamus, LW Huestis, CM Wong, J Dalgarno, D Holt, DA
Citation: W. Yang et al., Selective epimerization of rapamycin via a retroaldol/aldol mechanism mediated by titanium tetraisopropoxide, ORG LETT, 1(12), 1999, pp. 2033-2035
Endogenous mouse interleukin-10 is up-regulated by exogenously administered recombinant human interleukin-10, but does not contribute to the efficacyof the human protein in mouse models of endotoxemia
Authors: Smith, SR Terminelli, C Denhardt, G Manfra, D Davies, L Narula, S
Citation: Sr. Smith et al., Endogenous mouse interleukin-10 is up-regulated by exogenously administered recombinant human interleukin-10, but does not contribute to the efficacyof the human protein in mouse models of endotoxemia, IMMUNOPHARM, 41(2), 1999, pp. 119-130
Variability in lesion location after microelectrode-guided pallidotomy forParkinson's disease: anatomical, physiological, and technical factors thatdetermine lesion distribution
Authors: Gross, RE Lombardi, WJ Hutchison, WD Narula, S Saint-Cyr, JA Dostrovsky, JO Tasker, RR Lang, AE Lozano, AM
Citation: Re. Gross et al., Variability in lesion location after microelectrode-guided pallidotomy forParkinson's disease: anatomical, physiological, and technical factors thatdetermine lesion distribution, J NEUROSURG, 90(3), 1999, pp. 468-477
Induction of CD4(+) T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta(1)
Authors: Zeller, JC Panoskaltsis-Mortari, A Murphy, WJ Ruscetti, FW Narula, S Roncarolo, MG Blazar, BR
Citation: Jc. Zeller et al., Induction of CD4(+) T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta(1), J IMMUNOL, 163(7), 1999, pp. 3684-3691
Risultati: 1-11 |